Please use this identifier to cite or link to this item: https://islhd.intersearch.com.au/islhdjspui/handle/1/6720
Full metadata record
DC FieldValueLanguage
dc.contributor.authorParmar Gen
dc.contributor.authorCapra Men
dc.contributor.authorHungria Ven
dc.contributor.authorSeguro FSen
dc.contributor.authorDimopoulos MAen
dc.contributor.authorDelimpasi Sen
dc.contributor.authorŠpička Ien
dc.contributor.authorMinařík Jen
dc.contributor.authorMarques Hen
dc.contributor.authorPour Len
dc.contributor.authorMihályová Jen
dc.contributor.authorYuda Jen
dc.contributor.authorSunami Ken
dc.contributor.authorEsteves Gen
dc.contributor.authorChmielewski Cen
dc.contributor.authorSoufflet Cen
dc.contributor.authorYu Den
dc.contributor.authorComerford Een
dc.contributor.authorSuzan Fen
dc.contributor.authorCordero Pen
dc.contributor.authorZhang Ren
dc.contributor.authorQuach Hen
dc.date.accessioned2026-10-29T00:17:17Z-
dc.date.available2026-10-29T00:17:17Z-
dc.date.issued2026-10-01-
dc.identifier.citationClin Lymphoma Myeloma Leuk. 2026 Sep 3:S2152-2650(26)03286-6. doi: 10.1016/j.clml.2026.08.019.en
dc.identifier.urihttps://islhd.intersearch.com.au/islhdjspui/handle/1/6720-
dc.subjectPatient Reported Outcomes-
dc.subjectMyeloma-
dc.titlePatient-reported Outcomes and Healthcare Provider Perspectives on Subcutaneous Isatuximab Delivery via On-body Injector Versus Manual Injection: Results From the Phase 2 IZALCO Study in Relapsed/Refractory Multiple Myelomaen
dc.identifier.journaltitleClin Lymphoma Myeloma Leuken
dc.identifier.doi10.1016/j.clml.2026.08.019en
dc.contributor.islhdParmar, Gurdeepen
Appears in Collections:Research publications from current and former ISLHD staff.

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.